Lean Six Sigma and QbD

Quality by Design (QbD) is a science- and risk-based approach outlined in ICH Q8, Q9, and Q10. It emphasizes that product quality should not be tested into the final dosage form but must be built into it from the very beginning. QbD requires systematic identification of Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs), and Critical Process Parameters (CPPs).

These elements are studied through structured experimentation, most often with Design of Experiments (DOE), to establish a robust design space within which a process consistently delivers quality outcomes. QbD, therefore, focuses on answering the regulatory and scientific question: “What defines a robust formulation and process that can assure patient safety and product efficacy?”

Lean Six Sigma (LSS), in contrast, originates from business and industrial excellence programs. Its objective is to minimize process variation (Six Sigma) and eliminate waste (Lean) in order to achieve efficiency, predictability, and reduced costs. Lean Six Sigma applies the DMAIC cycle (Define, Measure, Analyze, Improve, Control) and uses data-driven tools such as process capability indices (Cp and Cpk), control charts, root cause analysis, Pareto analysis, and Failure Mode and Effects Analysis (FMEA). It addresses the operational question: “How do we make this process more efficient, consistent, and cost-effective over time?”

The synergy between these two approaches lies in the fact that QbD defines the design space, while LSS ensures that processes operate within that space with minimal variability and maximum efficiency. For example, a QbD study may establish that an optimal granulation endpoint lies between 3.5 and 4.0 percent loss on drying. Lean Six Sigma, through statistical monitoring and capability studies, ensures that the process remains within this range, targeting a high Cp/Cpk value that reflects consistent and reproducible performance.

In practical terms, QbD builds robustness into the formulation and process design, while Lean Six Sigma sustains that robustness by controlling variability and continuously improving efficiency. Together, they provide a dual advantage: regulatory compliance through scientific justification and operational excellence through efficiency and waste reduction. This integration not only strengthens regulatory submissions and inspections but also reduces rework, minimizes batch failures, and lowers the cost of goods.


Related Topics:

QbD SummaryDoEQbD Tools
BioequivalenceBiotechnologyBioinformatics


Resource Person: Moinuddin Syed. Ph.D, PMP®

Leave a Comment